STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTs

Withdrawn before enrolling · Not applicable

Conditions studied: Hepatitis C, Hepatocellular Carcinoma

In brief

The investigators will conduct a randomized controlled trial comparing two strategies to promote HCV screening, follow-up testing, and treatment among Parkland patients who are 18 years or older who have elevated liver functioning test (LFT) results: in reach with electronic medical record alerts and provider education vs. combination of in reach and provider education plus mailed outreach and patient navigation.

Key facts

Study ID

NCT04395118

Run by

University of Texas Southwestern Medical Center

People needed

0

Starts

2020-08-15

Expected to finish

2022-01-01

Last updated by the study team

2020-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• ages 18 or older
• elevated liver functioning tests (AST or ALT >35 that are separated by at least one month)
• ≥ 1 outpatient visit during 12 months prior to randomization at Parkland
• no prior HCV screening (prior HCV antibody, viral load, or genotype).
• any active medical coverage
• speaks Spanish or English

You may not qualify if…

• a life expectancy less than one year including any history of metastatic cancer, and those who received a palliative care or hospice referral in the past year
• history of HCC.
• non-English or Spanish speakers
• no address or phone number on file

Where it is running

• Parkland Hospital — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.